We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Tenable Holdings
TENB
$3.56B
| $45K | ﹤0.01% |
2,662
+801
| +43% | +$16.8K |
|
1702
Innospec
IOSP
$2.09B
| $45K | ﹤0.01% |
616
+159
| +35% | +$12.4K |
|
1703
ePlus
PLUS
$2.33B
| $44.9K | ﹤0.01% |
597
+171
| +40% | +$14K |
|
1704
Spyre Therapeutics
SYRE
$8.87B
| $44.8K | ﹤0.01% |
888
+232
| +35% | +$8.75K |
|
1705
Kaiser Aluminum
KALU
$2.67B
| $44.7K | ﹤0.01% |
371
+98
| +36% | +$12.4K |
|
1706
Diodes
DIOD
$4B
| $44.6K | ﹤0.01% |
654
+181
| +38% | +$11.4K |
|
1707
St. Joe Company
JOE
$3.57B
| $44.5K | ﹤0.01% |
709
+194
| +38% | +$13K |
|
1708
Acadia Healthcare
ACHC
$3.17B
| $44.4K | ﹤0.01% |
1,900
+455
| +31% | +$8.24K |
|
|
APLS
1709
DELISTED
Apellis Pharmaceuticals
APLS
| $44.3K | ﹤0.01% |
1,100
+260
| +31% | +$5.6K |
|
1710
Centuri Holdings
CTRI
$2.79B
| $44K | ﹤0.01% |
1,508
+474
| +46% | +$13.8K |
|
1711
DNOW Inc
DNOW
$2.63B
| $44K | ﹤0.01% |
3,694
-44,401
| -92% | -$601K |
|
1712
ImmunityBio
IBRX
$7.44B
| $44K | ﹤0.01% |
5,735
+1,905
| +50% | +$13K |
|
1713
Insight Enterprises
NSIT
$3.55B
| $44K | ﹤0.01% |
656
+185
| +39% | +$15.1K |
|
1714
Genworth Financial
GNW
$3.8B
| $43.6K | ﹤0.01% |
5,367
+274
| +5% | +$2.32K |
|
1715
Capri Holdings
CPRI
$1.77B
| $43.5K | ﹤0.01% |
2,468
+671
| +37% | +$14.2K |
|
1716
American Express Global Business Travel
GBTG
$4.91B
| $43.4K | ﹤0.01% |
7,772
+4,000
| +106% | +$24.8K |
|
1717
Hawaiian Electric Industries
HE
$2.33B
| $43.3K | ﹤0.01% |
2,919
+707
| +32% | +$10.7K |
|
1718
Liquidia Corp
LQDA
$7.67B
| $43.2K | ﹤0.01% |
1,144
+281
| +33% | +$10.4K |
|
1719
Remitly
RELY
$4.74B
| $43.2K | ﹤0.01% |
2,754
+702
| +34% | +$10.4K |
|
1720
DoubleVerify
DV
$1.62B
| $42.7K | ﹤0.01% |
4,490
+1,826
| +69% | +$18.7K |
|
1721
Calumet Specialty Products
CLMT
$3.63B
| $42.6K | ﹤0.01% |
1,188
+227
| +24% | +$5.88K |
|
1722
Excelerate Energy
EE
$1.23B
| $42.4K | ﹤0.01% |
1,268
+323
| +34% | +$11.6K |
|
1723
ScottsMiracle-Gro
SMG
$4.03B
| $42.3K | ﹤0.01% |
696
+155
| +29% | +$10K |
|
1724
Polaris
PII
$4.15B
| $42.1K | ﹤0.01% |
772
+159
| +26% | +$9.96K |
|
1725
Credit Acceptance
CACC
$6B
| $41.9K | ﹤0.01% |
99
+17
| +21% | +$8.02K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.